ABAXIS (NASDAQ: ABAX) and Hansen Medical (NASDAQ:HNSN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitabiliy, earnings, institutional ownership and dividends.

Institutional & Insider Ownership

98.1% of ABAXIS shares are owned by institutional investors. 4.1% of ABAXIS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares ABAXIS and Hansen Medical’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
ABAXIS $227.22 million 5.29 $51.83 million $1.43 37.08
Hansen Medical N/A N/A N/A N/A N/A

ABAXIS has higher revenue and earnings than Hansen Medical.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for ABAXIS and Hansen Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ABAXIS 2 4 1 0 1.86
Hansen Medical 0 0 0 0 N/A

ABAXIS currently has a consensus price target of $47.88, suggesting a potential downside of 9.70%. Given ABAXIS’s higher possible upside, analysts plainly believe ABAXIS is more favorable than Hansen Medical.


This table compares ABAXIS and Hansen Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ABAXIS 14.40% 11.37% 9.95%
Hansen Medical -317.95% N/A -96.52%

Risk & Volatility

ABAXIS has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Hansen Medical has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500.


ABAXIS pays an annual dividend of $0.56 per share and has a dividend yield of 1.1%. Hansen Medical does not pay a dividend. ABAXIS pays out 39.2% of its earnings in the form of a dividend.


ABAXIS beats Hansen Medical on 10 of the 11 factors compared between the two stocks.

ABAXIS Company Profile

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company’s segments are the medical market and the veterinary market. The Company’s medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company’s veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Hansen Medical Company Profile

Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System. Its Sensei system allows physicians to navigate catheters in interventional procedures within the atrial heart chambers. Its disposable Artisan Extend catheter assembly consists of a telescoping set of control catheters. Its CoHesion 3D Visualization Module is a software interface between its Sensei system and the St. Jude Medical EnSite System for Electro-Physiology procedures. The Magellan System controls the Magellan Robotic Catheter, which is a telescoping, steerable catheter designed to facilitate remote catheter navigation and vessel cannulation.

Receive News & Ratings for ABAXIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABAXIS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.